230 related articles for article (PubMed ID: 32296587)
1. Preparation, characterization, pharmacokinetics and anticancer effects of PEGylated β-elemene liposomes.
Zhai B; Wu Q; Wang W; Zhang M; Han X; Li Q; Chen P; Chen X; Huang X; Li G; Zhang Q; Zhang R; Xiang Y; Liu S; Duan T; Lou J; Xie T; Sui X
Cancer Biol Med; 2020 Feb; 17(1):60-75. PubMed ID: 32296587
[No Abstract] [Full Text] [Related]
2. An ATF
Zhai B; Chen P; Wang W; Liu S; Feng J; Duan T; Xiang Y; Zhang R; Zhang M; Han X; Chen X; Li Q; Li G; Liu Y; Huang X; Zhang W; Pan T; Yan L; Jin T; Xie T; Sui X
Cancer Biol Med; 2020 Aug; 17(3):676-692. PubMed ID: 32944399
[No Abstract] [Full Text] [Related]
3. Preparation, characterization and relative bioavailability of oral elemene o/w microemulsion.
Zeng Z; Zhou G; Wang X; Huang EZ; Zhan X; Liu J; Wang S; Wang A; Li H; Pei X; Xie T
Int J Nanomedicine; 2010 Sep; 5():567-72. PubMed ID: 20856831
[TBL] [Abstract][Full Text] [Related]
4. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
Dadashzadeh S; Vali AM; Rezaie M
Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
[TBL] [Abstract][Full Text] [Related]
5. [Study on pharmacokinetics of PVP coated beta-elemene liposome in rats].
Zhang XY; Deng YJ; Zhao CJ; Wang XM; Li Z; Gao XF
Zhong Yao Cai; 2006 Feb; 29(2):157-60. PubMed ID: 16617787
[TBL] [Abstract][Full Text] [Related]
6. Preparation, Characterization, and In Vitro Pharmacodynamics and Pharmacokinetics Evaluation of PEGylated Urolithin A Liposomes.
Yi S; Zhang C; Hu J; Meng Y; Chen L; Yu H; Li S; Wang G; Zheng G; Qiu Z
AAPS PharmSciTech; 2021 Jan; 22(1):26. PubMed ID: 33404864
[TBL] [Abstract][Full Text] [Related]
7. The Preparation, Determination of a Flexible Complex Liposome Co-Loaded with Cabazitaxel and β-Elemene, and Animal Pharmacodynamics on Paclitaxel-Resistant Lung Adenocarcinoma.
Zeng YY; Zeng YJ; Zhang NN; Li CX; Xie T; Zeng ZW
Molecules; 2019 Apr; 24(9):. PubMed ID: 31052317
[TBL] [Abstract][Full Text] [Related]
8. PEGylated liposomes as delivery systems for Gambogenic acid: Characterization and in vitro/in vivo evaluation.
Tang X; Sun J; Ge T; Zhang K; Gui Q; Zhang S; Chen W
Colloids Surf B Biointerfaces; 2018 Dec; 172():26-36. PubMed ID: 30125771
[TBL] [Abstract][Full Text] [Related]
9. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
[TBL] [Abstract][Full Text] [Related]
10. Tumor microenvironment responsive VEGF-antibody functionalized pH sensitive liposomes of docetaxel for augmented breast cancer therapy.
Jain S; Deore SV; Ghadi R; Chaudhari D; Kuche K; Katiyar SS
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111832. PubMed ID: 33579470
[TBL] [Abstract][Full Text] [Related]
11. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
[TBL] [Abstract][Full Text] [Related]
12. High drug payload curcumin nanosuspensions stabilized by mPEG-DSPE and SPC: in vitro and in vivo evaluation.
Hong J; Liu Y; Xiao Y; Yang X; Su W; Zhang M; Liao Y; Kuang H; Wang X
Drug Deliv; 2017 Nov; 24(1):109-120. PubMed ID: 28155567
[TBL] [Abstract][Full Text] [Related]
13. [The pharmacokinetics of long-circulating beta-elemene liposomes].
Zhang BJ; Li WC; Liu XP
Zhong Yao Cai; 2012 Sep; 35(9):1464-8. PubMed ID: 23451504
[TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes.
Crosasso P; Ceruti M; Brusa P; Arpicco S; Dosio F; Cattel L
J Control Release; 2000 Jan; 63(1-2):19-30. PubMed ID: 10640577
[TBL] [Abstract][Full Text] [Related]
15. [Preparation of cell penetrating peptide TAT and cleavable PEGco-modified liposomes loaded with paclitaxel and its in vitro apoptosis assay].
Fu H; Hu GL; He Q
Yao Xue Xue Bao; 2014 Jul; 49(7):1054-61. PubMed ID: 25233640
[TBL] [Abstract][Full Text] [Related]
16. Drug delivery systems for elemene, its main active ingredient β-elemene, and its derivatives in cancer therapy.
Zhai B; Zeng Y; Zeng Z; Zhang N; Li C; Zeng Y; You Y; Wang S; Chen X; Sui X; Xie T
Int J Nanomedicine; 2018; 13():6279-6296. PubMed ID: 30349250
[TBL] [Abstract][Full Text] [Related]
17. Novel Long-Circulating Liposomes Consisting of PEG Modified β-Sitosterol for Gambogic Acid Delivery.
Yu F; Tang X
J Nanosci Nanotechnol; 2016 Mar; 16(3):3115-21. PubMed ID: 27455771
[TBL] [Abstract][Full Text] [Related]
18. Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin.
Swaminathan J; Gobbo OL; Tewes F; Healy AM; Ehrhardt C
J Aerosol Med Pulm Drug Deliv; 2014 Feb; 27(1):1-11. PubMed ID: 24252061
[TBL] [Abstract][Full Text] [Related]
19. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
[TBL] [Abstract][Full Text] [Related]
20. Characterization and body distribution of beta-elemene solid lipid nanoparticles (SLN).
Wang Y; Deng Y; Mao S; Jin S; Wang J; Bi D
Drug Dev Ind Pharm; 2005 Sep; 31(8):769-78. PubMed ID: 16221611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
